NEW YORK (GenomeWeb) – Zymergen announced today that it has acquired metagenomics firm Radiant Genomics.
According to Zymergen, Radiant has built large-scale libraries of genetic diversity using a platform that combines sequencing, bioinformatics, synthetic biology, and other technologies for natural product discovery, diversification, and production. Zymergen said it will use Radiant's technologies and platform to identify and commercialize novel molecules for uses in areas such as agriculture, healthcare, and chemicals.
Zymergen added that it will bring on board Radiant's entire team, including Founders Jeffrey Kim and Oliver Liu. Additional terms of the deal were not disclosed.
"The molecules biology produces on its own could provide solutions to some of the toughest challenges across industries," Zymergen CEO Joshua Hoffman said in a statement. "Radiant has built an unparalleled platform and set of libraries to search genetic diversity that will allow us to search for these molecules of interest, extending our ability to produce useful molecules for materials that can transform the world around us."